Predictive factors for treatment success of transforaminal epidural steroid injection in lumbar disc herniation-induced sciatica.
The aim of this study was to identify predictive factors for treatment success of transforaminal epidural steroid injection in patients with lumbar disc herniation-induced sciatica. A total of 219 patients who were diagnosed with unilateral sciatica and underwent transforaminal epidural steroid injection at the level of L4-5, L5-S1 or S1 neural foramina between March 2016 and May 2018 were retrospectively analyzed. The presence of transitional vertebrae and the grade of nerve root compression were evaluated by a radiologist. Data including age, sex, body mass index, duration of symptoms, injection levels and pain scores recorded. Pain scores were evaluated using the Numerical Rating Scale. Treatment success was defined as a ?50% decrease in the pain scores at three months. Of the patients 118 were females and 101 were males with a mean age of 43.65±12.18 years. The mean duration of symptoms was 25.64±2.17 weeks. Although the duration of symptoms was longer in patients in whom treatment failed, it did not reach statistical significance. Decreased pain scores at one hour had a significant effect on the treatment success (p=0.012, OR: 1.015 95% CI, 1.003-1.026). Our study results suggest that decreased pain scores at one hour are predictors for a favorable three-month response to transforaminal epidural steroid injection in patients with lumbar disc herniation-induced sciatica.